Peking University People's Hospital clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
4 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 3 with minor changes only.
- Minor: PCB-Risk · Predicting the Risk of Partial Ciliary Block After Cataract and Goniosynechialysis Surgery in Primary Angle-Closure Disease Trial status changed: Not Yet Recruiting → Active, Not Recruiting
- Notable: Optimal Dose of Zanubrutinib · Adult Immune Thrombocytopenia Phase changed: Phase 1 → Phase 2
-
Minor: 2 trials marked Unknown by the registry's verification sweep Changed
- Minor: Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT Changed Registry marked status Unknown (sponsor has not verified the record since Mar 2020); last known: Recruiting
- Minor: Performance of Urine HPV Testing in Males Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-12 | NCT07933120 Model of Vaginal Laxity | Not Yet Recruiting | |
| 2026-11-09 | NCT07923968 The Preventive Efficacy of ULP for Stress Urinary Incontinence After Pelvic Organ… | Not Yet Recruiting | |
| 2026-11-09 | NCT07924553 Efficacy, Safety and Cardiovascular Protection of Mazdutide in Type 1 Diabetes | Not Yet Recruiting | |
| 2026-11-09 | NCT07925554 Interferon-α Maintenance in Favorable-Risk AML | Phase 2 | Recruiting |
| 2026-11-05 | NCT07919470 Busulfan-Based Versus TBI-Based Conditioning for Adult ALL-CR2 Allo-HSCT | Not Yet Recruiting | |
| 2026-10-29 | NCT07905066 Hemophagocytic Lymphohistiocytosis After Allogeneic Stem Cell Transplantation | Recruiting | |
| 2026-10-26 | NCT07894458 MRD-Guided Postoperative Surveillance and Adaptive Treatment for Resectable Lung Cancer | Recruiting | |
| 2026-10-21 | NCT07885709 MRD and Imaging Guided Adaptive Neoadjuvant Therapy for Resectable NSCLC | Phase 2 | Not Yet Recruiting |
Active trials by phase
| Early Phase 1 | 6 | |
| Phase 1 | 6 | |
| Phase 1/2 | 10 | |
| Phase 2 | 41 | |
| Phase 2/3 | 1 | |
| Phase 3 | 6 | |
| Phase 4 | 4 |
Not charted: 136 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 40
Leukemia (32) · Breast Cancer (17) · Lung Cancer (16) · Acute Myeloid Leukemia (AML) (15) · Endometrial Cancer (13) · Non-Small Cell Lung Cancer (NSCLC) (11) · Sarcoma (10) · Myelodysplastic Syndromes (MDS) (9) · Acute Lymphoblastic Leukemia (ALL) (8) · Multiple Myeloma (6)
Get alerts when Peking University People's Hospital's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.